Combined therapeutic effect of YHO-1701 with PD-1 blockade is dependent on natural killer cell activity in syngeneic mouse models. - Takahashi H; Miyoshi N; Murakami H; Okamura Y; Ogo N; Takagi A; Muraoka D; Asai A (Cancer immunology, immunotherapy : CII, 2023)